Kahled, I think you are SPOT ON...Dan had unrealistic goals of making a huge stand alone pharma..nope, not happening...so, out he goes..now, they sell the HER2 science...raise some cake...then they concentrate on the other trials and get them off to partners for full approvals and cash/royalties income...then work on the big bananas with NEO. I know it takes guts to buy low and sell high, but here if where you fiond out what type of real investor you are...take good facts about science, no real bad news at all on this...shrug off the ploys of hedge funds and Adage doing possibly illegal manipulations/HFT.....and average down for the future gain...